Panbela Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Panbela Therapeutics

16/03/2023 21:43

* Panbela Therapeutics Inc  PBLA.OQ  reported a quarterly
adjusted
loss of $5.68​​ per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was for a loss
of $3.70 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Panbela Therapeutics Inc's reported EPS for the quarter
was a
loss of $5.68​.
    * The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Panbela Therapeutics Inc shares had fallen by 77.3% this
quarter.
    * The company reported a quarterly loss of $4.73 million.
    * Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 16 at 09:43 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -3.70          -5.68          Missed
 Sep. 30 2022      -8.80          -8.40          Beat
 Jun. 30 2022      -10.13         -60.40         Missed
 Mar. 31 2022      -10.20         -10.80         Missed